Overview
: Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy Volunteers
Status:
Active, not recruiting
Active, not recruiting
Trial end date:
2023-04-01
2023-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to compare pharmacokinetics and safety of Irbesartan High and Amlodipine Fixed Dose Combination and coadministration of mono compounds in healthy adult volunteersPhase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Handok Inc.Treatments:
Amlodipine
Irbesartan
Criteria
Inclusion Criteria:- Patients who are 19 years or older on screening
- Signed informed consent
- Healthy Volunteer
- Other inclusion applied
Exclusion Criteria:
- Clinically relevant/significant findings as evaluated by the investigator
- Other exclusion applied